Form 4: HCA Healthcare SVP Kathleen Whalen Reports Stock Transactions
SEC Form 4 Filing
Kathleen M. Whalen, SVP & Chief Ethics Officer of HCA Healthcare, reports multiple transactions involving common stock and stock appreciation rights.
Summary
- Kathleen M. Whalen, a Senior Vice President and Chief Ethics Officer at HCA Healthcare, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- On May 16, 2024, she disposed of 3,204 shares of common stock at a price of $326.3 per share.
- On May 17, 2024, she acquired 3,040 shares of common stock through the exercise of stock appreciation rights at a price of $101.16 and 1,685 shares at $133.53.
- Also on May 17, 2024, she disposed of 2,861 shares of common stock at $322.86.
- Following these transactions, Whalen directly owns 11,318 shares of HCA Healthcare common stock and 12,045 stock appreciation rights.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice for corporate insiders to report their transactions in company stock, providing transparency to investors.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis to gauge management's sentiment and potential future performance.
- Comparing Whalen's transactions to those of other executives at HCA Healthcare and peer companies like Universal Health Services or Tenet Healthcare could provide further insights.
- Analyzing the timing and volume of these transactions relative to industry trends and company-specific news can be valuable.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.
- The filing ensures transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 2019-01-03 | Date of Power of Attorney execution. |
| 2019-01-31 | First vesting date of stock appreciation rights (3,040 shares). |
| 2019-10-31 | First vesting date of stock appreciation rights (1,685 shares). |
| 2024-05-16 | Sale of 3,204 shares of common stock at $326.3. |
| 2024-05-17 | Exercise of stock appreciation rights and sale of shares. |
| 2024-05-20 | Date of signature for the Form 4 filing. |
| 2028-01-31 | Expiration date of stock appreciation rights (3,040 shares). |
| 2028-10-31 | Expiration date of stock appreciation rights (1,685 shares). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.